CE Marking

Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™

This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately.

Partnersgip

Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health

The collaboration donates and supports AI for making breast cancer screening more accessible and available in impoverished regions of the world

Therapixel-launched-new-website-Therapixel

Scientific Publications

Performances of using Mammoscreen™️ have been demonstrated in a multiple scientific publications. We are currently working on many projects in both the US and Europe.

Therapixel participates at the JFR 2020

Therapixel participates in the Journées Francophones de Radiologie 2020

Experience the Award-winning MammoScreen™ at our virtual booth on the online platform JFR.plus

Therapixel is certified ISO 27001

Therapixel is now ISO/IEC 27001 certified

Our information security management system is compliant with the world gold standard, ensuring a high level of cybersecurity.

MammoScreen received 510(k) clearance

Therapixel receives FDA 510(k) clearance for MammoScreen™

AI-powered reading aid for screening mammography improves Radiologists’ performance in cancer detection